Stem cell therapy clinical research: a regulatory conundrum for academia

Simple item page
dc.contributor.authorNagpal, A.
dc.contributor.authorJuttner, C.
dc.contributor.authorHamilton-Bruce, M.
dc.contributor.authorRolan, P.
dc.contributor.authorKoblar, S.
dc.date.issued2017
dc.description.abstractAbstract not available
dc.description.statementofresponsibilityAnjali Nagpal, Chris Juttner, Monica Anne Hamilton-Bruce, Paul Rolan, Simon A. Koblar
dc.identifier.citationAdvanced Drug Delivery Reviews, 2017; 122:105-114
dc.identifier.doi10.1016/j.addr.2016.10.001
dc.identifier.issn0169-409X
dc.identifier.issn1872-8294
dc.identifier.orcidHamilton-Bruce, M. [0000-0002-5222-620X]
dc.identifier.orcidKoblar, S. [0000-0002-8667-203X]
dc.identifier.urihttp://hdl.handle.net/2440/115400
dc.language.isoen
dc.publisherElsevier
dc.rights© 2016 Elsevier B.V. All rights reserved.
dc.source.urihttps://doi.org/10.1016/j.addr.2016.10.001
dc.subjectCell therapy; regenerative medicine; academic research; regulatory policy; innovative medical practice
dc.titleStem cell therapy clinical research: a regulatory conundrum for academia
dc.typeJournal article
pubs.publication-statusPublished

Files

Collections

Medicine publications